Position
Creative Planning in Nurix Therapeutics, Inc.
Back to the book · All holders of NRIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$62.8K$18.97 → $15.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 18.1K | $343.4K | — | — | — | 0.0% |
| Q1 2026 | 19.1K | $296.4K | $15.50 | −$62.8K | $15.8K | 0.0% |